Development of novel 1,4-benzodiazepine-based Michael acceptors as antitrypanosomal agents
作者:Roberta Ettari、Santo Previti、Sandro Cosconati、Santina Maiorana、Tanja Schirmeister、Silvana Grasso、Maria Zappalà
DOI:10.1016/j.bmcl.2016.06.047
日期:2016.8
prediction of their pharmacokinetic parameters. Among all the synthesized derivatives, we identified a new lead compound (i.e., 4a), bearing a vinyl ketone warhead and endowed with a promising antitrypanosomal activity against Trypanosoma brucei brucei (IC50=5.29μM), coupled with a lack of cytotoxicity towards mammalian cells (TC50 >100μM).
设计了具有迈克尔受体部分的新型1,4-苯并二氮杂taking,是利用其药代动力学参数的计算预测来设计的。在所有合成的衍生物中,我们确定了一种新的先导化合物(即4a),该化合物带有乙烯基酮战斗部,并具有对布鲁氏锥虫(Trypanosoma brucei brucei)的有希望的抗锥虫活性(IC50 =5.29μM),并且缺乏对哺乳动物细胞的细胞毒性(TC50>100μM)。